ADIL Stock Analysis: Buy, Sell, or Hold?
ADIL - Adial Pharmaceuticals, Inc
$3.64
0.30 (8.98%)
▲
5d:
+29.54%
30d:
+25.52%
90d:
+134.84%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
8d
Get Alerted When ADIL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ADIL is 17.8% above its trading range ($3.09). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ADIL is 17.8% above its trading range ($3.09). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ADIL is currently trading at $3.64, which is considered extended relative to its 30-day fair value range of $2.60 to $3.09.
Technical Outlook: Technically, ADIL is in a strong uptrend. The price is approaching resistance at $3.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: ADIL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+92.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADIL is in a strong uptrend. The price is approaching resistance at $3.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: ADIL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+92.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.60 -
$3.09
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+17.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.0%)
- BULLISH: Trading 92.3% below Wall St target ($7.00)
- WARNING: Recommendation downgraded due to 17.8% overvaluation
Trading Range Analysis
30-Day Trading Range
$2.60 -
$3.09
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.50
Resistance Level
$3.69
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.26
Wall Street Target
$7.00
(+92.3%)
Share & Embed Analysis
Last updated: August 03, 2026 5:17 PM ET
Data refreshes hourly during market hours. Next update: 6:17 PM
Data refreshes hourly during market hours. Next update: 6:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADIL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 54 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$108 | 60 BUY |
